Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review
- PMID: 26174525
- PMCID: PMC4484690
- DOI: 10.1177/070674371506000503
Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review
Erratum in
-
Erratum.Can J Psychiatry. 2015 Oct;60(10):426. Can J Psychiatry. 2015. PMID: 26720188 Free PMC article. No abstract available.
Abstract
Objective: It remains unclear whether antipsychotic polypharmacy, a common clinical practice, is related to an increased risk of corrected time between start of Q wave and end of T wave (QTc) interval prolongation. We conducted a systematic review of the literature to address this important issue.
Method: A systematic literature search was conducted in October 2014, using MEDLINE, Embase, and PsycINFO. Studies and case reports were included if they reported QTc intervals or QTc interval changes before and after antipsychotic polypharmacy or QTc intervals in both antipsychotic polypharmacy and monotherapy groups.
Results: A total of 21 articles (10 clinical trials, 4 observational studies, and 7 case reports) met inclusion criteria. The clinical trials have shown that a combination treatment with risperidone or pimozide is not obviously related to an increase in QTc interval, whereas ziprasidone or sertindole combined with clozapine may prolong QTc interval. Among the 4 observational studies, antipsychotic polypharmacy was not clearly associated with QTc prolongation in 3 studies, each cross-sectional. In contrast, one prospective study showed a significant increase in QTc interval following antipsychotic coadministration. The case reports indicated an increased risk of QTc prolongation in at least some patients receiving antipsychotic polypharmacy.
Conclusions: Currently available evidence fails to confirm that antipsychotic polypharmacy worsens QTc prolongation in general, although the evidence is scarce and inconsistent. Clinicians are advised to remain conservative in resorting to antipsychotic polypharmacy, as a combination of some QTc-prolongation liable antipsychotics may further prolong QTc interval, and efficacy supporting the clinical benefits of antipsychotic polypharmacy is equivocal, at best.
Objectif :: Il reste à déterminer si la polypharmacie antipsychotique, une pratique clinique courante, est liée à un risque accru de temps corrigé dans l’allongement de l’intervalle entre le début de l’onde Q et la fin de l’onde T (QTc). Nous avons mené une revue systématique de la littérature pour aborder ce problème important.
Méthode :: Une recherche systématique de la littérature a été menée en octobre 2014, dans les bases de données MEDLINE, Embase et PsycINFO. Les études et les études de cas étaient incluses si elles rendaient compte d’intervalles QTc ou de changements d’intervalles QTc avant et après la polypharmacie antipsychotique ou d’intervalles QTc dans les groupes de polypharmacie antipsychotique et de monothérapie.
Résultats :: Un total de 21 articles (10 essais cliniques, 4 études par observation, et 7 études de cas) satisfaisaient aux critères d’inclusion. Les essais cliniques ont montré qu’un traitement combiné par rispéridone ou pimozide n’est pas clairement lié à une augmentation de l’intervalle QTc, alors que la ziprasidone ou le sertindole combiné à la clozapine peuvent prolonger l’intervalle QTc. Dans les 4 études par observation, la polypharmacie antipsychotique n’était pas clairement associée à l’allongement du QTc dans 3 études, toutes transversales. Par contre, une étude prospective montrait une augmentation significative de l’intervalle QTc suivant une co-administration antipsychotique. Les études de cas indiquaient un risque accru d’allongement du QTc chez au moins certains patients recevant une polypharmacie antipsychotique.
Conclusions :: Les données probantes actuellement disponibles ne confirment pas que la polypharmacie antipsychotique aggrave l’allongement du QTc en général, car les données probantes sont rares et non consistantes. Il est recommandé que les cliniciens demeurent prudents lorsqu’ils ont recours à la polypharmacie antipsychotique, étant donné qu’une combinaison de certains antipsychotiques est susceptible de prolonger davantage l’intervalle QTc, et que l’efficacité à l’appui des avantages cliniques de la polypharmacie antipsychotique est au mieux équivoque.
Figures
Similar articles
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Cardiac safety of antipsychotic medications in pediatric and adolescent population: a systematic review and pathways for future research.Eur J Pediatr. 2024 Nov 16;184(1):20. doi: 10.1007/s00431-024-05885-w. Eur J Pediatr. 2024. PMID: 39549076
-
Risperidone versus other atypical antipsychotics for schizophrenia.Cochrane Database Syst Rev. 2011 Jan 19;2011(1):CD006626. doi: 10.1002/14651858.CD006626.pub2. Cochrane Database Syst Rev. 2011. PMID: 21249678 Free PMC article.
-
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543555
-
Atypical antipsychotics for disruptive behaviour disorders in children and youths.Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3. Cochrane Database Syst Rev. 2017. PMID: 28791693 Free PMC article.
Cited by
-
[Schizophrenia spectrum disorders in elderly patients : Analysis of reasons for admission to a department of geriatric psychiatry].Z Gerontol Geriatr. 2018 Feb;51(2):206-212. doi: 10.1007/s00391-016-1107-0. Epub 2016 Jul 19. Z Gerontol Geriatr. 2018. PMID: 27436219 German.
-
Risk factors for polypharmacy in older adults in a primary care setting: a cross-sectional study.Clin Interv Aging. 2018 Oct 15;13:2003-2011. doi: 10.2147/CIA.S176329. eCollection 2018. Clin Interv Aging. 2018. PMID: 30410317 Free PMC article.
-
QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review.Neuropsychiatr Dis Treat. 2021 Dec 24;17:3791-3818. doi: 10.2147/NDT.S324145. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34992373 Free PMC article. Review.
-
Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia.Int J Neuropsychopharmacol. 2023 Aug 29;26(8):557-565. doi: 10.1093/ijnp/pyad037. Int J Neuropsychopharmacol. 2023. PMID: 37381793 Free PMC article.
-
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.PLoS One. 2016 Feb 3;11(2):e0148212. doi: 10.1371/journal.pone.0148212. eCollection 2016. PLoS One. 2016. PMID: 26840602 Free PMC article.
References
-
- Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951–962. - PubMed
-
- Hasnain M, Vieweg W. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review. CNS Drugs. 2014;28(10):887–920. - PubMed
-
- CredibleMeds Worldwide. Oro Valley (AZ): CredibleMeds Worldwide; 2014. QTdrugs list. [cited 2014 Dec 28]. Available from: https://www.crediblemeds.org/new-drug-list.
-
- Kongsamut S, Kang J, Chen XL, et al. A comparison of the receptor binding and hERG channel affinities for a series of antipsychotic drugs. Eur J Pharmacol. 2002;450(1):37–41. - PubMed
-
- Titier K, Canal M, Déridet E, et al. Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice. Toxicol Appl Pharmacol. 2004;199(1):52–60. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous